Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
68 participants
INTERVENTIONAL
2017-03-24
2020-08-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Traumatic brain injury (TBI) damages the connections between brain cells. This can lead to problems like memory loss. Repetitive transcranial magnetic stimulation (rTMS) can help improve connections between brain areas in healthy people. Researchers want to see if it can be useful in patients with memory problems after TBI.
Objective:
To see how repetitive transcranial magnetic stimulation can be used to improve the connections between parts of the brain and whether this will lead to changes in memory.
Eligibility:
Adults 18-50 years old with TBI who can speak and write in English.
Healthy volunteers the same age and English ability.
Design:
Participants will be screened with a neurological exam and may have a urine pregnancy test.
Participants with TBI will have 7-15 visits. Healthy volunteers will have 2-8 visits.
At the visits, participants will have all or some of the following:
* MRI for about 1 hour. Participants will lie in a machine that takes pictures in a magnetic field. Participants will do some memory tasks.
* Memory and attention tasks with pictures and with a computer
* Questions about their mental state and well-being
* TMS: A wire coil is held on the scalp and a short electrical current passes through it. Participants will hear a click and feel a pulling or twitch. They may be asked to make simple movements. rTMS is repeated magnetic pulses in short bursts. They will have this for about 20 minutes.
A week after the last visit, some participants will return for a memory test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI
NCT03727737
rTMS for Cognitive Rehabilitation After TBI
NCT03642158
rTMS to Improve Cognitive Function in TBI
NCT02152540
Task-dependent Effects of TMS on the Neural Biomarkers of Episodic Memory
NCT04694131
Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)
NCT02367521
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study population: Healthy adult volunteers
Design: The study contains two experiments. Experiment 1 is designed to establish the number of rTMS sessions required to produce a meaningful change in resting parieto-hippocampal FC in healthy subjects. Experiment 2 will replicate a prior experiment which used rTMS to enhance the explicit memory system in healthy subjects, and look for potential effects on the implicit system. This intervention will be contrasted with a negative control condition (vertex stimulation) in a between-groups design.
Outcome measures: The primary outcome measure is the change in FC produced by serially applied rTMS and improvement in explicit memory. We will explore whether enhancement of the explicit system has effects on resting state connectivity in the implicit system and whether white matter integrity predicts changes in FC in healthy subjects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parietal Cortex rTMS stimulation - 1 day
Experiment 1
rTMS
Altering the connectivity of trans-synaptic pathways
Parietal Cortex rTMS stimulation - 3 days
Experiment 1
rTMS
Altering the connectivity of trans-synaptic pathways
Parietal Cortex rTMS stimulation - 4 days
Experiment 1
rTMS
Altering the connectivity of trans-synaptic pathways
Experiment 2 - Parietal Cortex rTMS stimulation - 3 days
Experiment 2
rTMS
Altering the connectivity of trans-synaptic pathways
Experiment 2 - Vertex rTMS stimulation - 3 days
Experiment 2
rTMS
Altering the connectivity of trans-synaptic pathways
Experiment 2 - Prefrontal Cortex rTMS stimulation - 3 days
Experiment 2
rTMS
Altering the connectivity of trans-synaptic pathways
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rTMS
Altering the connectivity of trans-synaptic pathways
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Healthy individuals
Age 18-50 (inclusive)
English speaking and writing
Experiment 3:
Age 18-50 (inclusive)
English speaking and writing
History of mild to moderate TBI
Performance 1 standard deviation below age-adjusted population norms on the
CVLT-2 within the past year from the date of visit.
Exclusion Criteria
History of seizure
Medications acting on the central nervous system
Ferromagnetic metal in the cranial cavity or eye, implanted neural stimulator, cochlear implant, or ocular foreign body
Implanted cardiac pacemaker or auto-defibrillator or pump
Non-removable body piercing
Claustrophobia
Inability to lie supine for 1 hour
Pregnancy, nursing, or plans to become pregnant during the study.
Members of the NINDS Behavioral Neurology Unit (BNU)
For Experiment 2: Participation in Experiment 1
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eric M Wassermann, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Neurological Disorders and Stroke (NINDS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Wang JX, Rogers LM, Gross EZ, Ryals AJ, Dokucu ME, Brandstatt KL, Hermiller MS, Voss JL. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science. 2014 Aug 29;345(6200):1054-7. doi: 10.1126/science.1252900.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-N-0055
Identifier Type: -
Identifier Source: secondary_id
170055
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.